Premium
Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia
Author(s) -
Aoki Aiko,
Yoneda Noriko,
Yoneda Satoshi,
Miyazono Takayoshi,
Sugiyama Toshiro,
Saito Shigeru
Publication year - 2011
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/j.1447-0756.2011.01598.x
Subject(s) - medicine , acute promyelocytic leukemia , idarubicin , disseminated intravascular coagulation , chemotherapy , pregnancy , leukemia , induction chemotherapy , gestation , tretinoin , retinoic acid , coagulopathy , gastroenterology , surgery , cytarabine , biochemistry , chemistry , genetics , biology , gene
A pregnant woman was diagnosed with acute promyelocytic leukemia at 38 weeks of gestation. Induction of labor was successful, and the patient delivered a healthy male baby. Soon after delivery, she was treated with chemotherapy using all‐ trans ‐retinoic acid (ATRA). The number of white blood cells was increased on the fifth postpartum day and retinoic acid syndrome (RAS) was considered a concern. On the sixth postpartum day, remission induction chemotherapy with idarubicin and cytosine arabinoside was started. On the seventh postpartum day, massive uterine bleeding of more than 1300 mL suddenly occurred. As administration of cytotoxic agents may induce disseminated intravascular coagulation, we should take care to avoid uterine bleeding after chemotherapy in acute promyelocytic leukemia cases treated soon after delivery.